|
|
|
This is the preliminary program for the 2006 Joint Statistical
Meetings in Seattle, Washington.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2006 Program page |
= Applied Session,
= Theme Session,
= Presenter, Sheraton Seattle Hotel & Towers = “S”
381
|
Wed, 8/9/06, 8:30 AM - 10:20 AM | CC-3A |
| Survival, Time to Event - Contributed - Papers | ||
|
Biopharmaceutical Section, Biometrics Section, ENAR |
||
| Chair(s): B. Christine Clark, ICON Clinical Research | ||
| 8:35 AM |
Predicting Time of Completion in Multiphase Survival Trials —  Dennis Sweitzer, AstraZeneca Pharmaceuticals
|
|
| 8:50 AM |
Power Calculation for Log-Rank Test under a Nonproportional Hazards Model — Daowen Zhang, sanofi-aventis; Hui Quan, sanofi-aventis
|
|
| 9:05 AM |
Use of Life Tables To Extrapolate Survival from Clinical Trial Data — W. J. Hall, University of Rochester Medical Center; Hongyue Wang, University of Rochester Medical Center
|
|
| 9:20 AM |
Analyzing Change in Hazard for Time-to-Event Endpoints in Clinical Trials — Rafia Bhore, U.S. Food and Drug Administration; Sandra Gardner, Sunnybrook Health Sciences Centre
|
|
| 9:35 AM |
Time to Rescue as a Surrogate Endpoint for Analgesic Efficacy in Acute Pain Studies — Julia Wang, Johnson & Johnson Pharmaceutical R&D; Akiko Okamoto, Johnson & Johnson Pharmaceutical R&D; Surya Mohanty, Johnson & Johnson Pharmaceutical R&D
|
|
| 9:50 AM |
On Analysis of Time to Progression — Zhiping Sun, Merck & Co., Inc.; Cong Chen, Merck & Co., Inc.
|
|
| 10:05 AM |
Testing for Change-Points in Waiting Time Distributions — Thomas Hammerstrom, U.S. Food and Drug Administration; Rafia Bhore, U.S. Food and Drug Administration
|
|
|
JSM 2006
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |